Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
169 people get ICLR articles and Market Currents by email alert.
Get email alerts on ICLR »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Apr 25, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Feb 4, 2013)
-
Strengthening Moats Mean Improving Returns For CRO InvestorsMorningstar • Mon, Dec 31, 2012 -
Business Wire (Dec 21, 2012)
-
Business Wire (Dec 3, 2012)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 6, 2012)
-
-
-
Business Wire (Jun 12, 2012)
-
-
-
Hedge Funds Are Buying Up These 20 Healthcare StocksKapitall • Thu, Jan 26, 2012
-
5 Stocks To Survive EurogeddonMyPlanIQ • Mon, Jan 23, 2012
To learn more about Seeking Alpha Pro, click here.
-
ICON and Fountain Medical Forge a Mutually Beneficial AllianceChinaBio Today • Wed, Jun 30, 2010 -
ICON Alliance With Chinese Tigermed Is Mutually BeneficialChinaBio Today • Thu, Apr 8, 2010
-
Icon Immune to Global RecessionVahan Janjigian • Tue, Dec 9, 2008 -
Icon - Even CROs with Decent Earnings Aren't ImmuneTraderMark • Tue, Oct 21, 2008 -
Icon Has the Luck of the IrishTraderMark • Fri, Feb 22, 2008
-
Icon's Solid Growth Expected To ContinueTate Dwinnell • Wed, Feb 14, 2007 -
The Long Case for ICON Clinical Public LimitedHans Wagner • Mon, Feb 12, 2007
-
Strengthening Moats Mean Improving Returns For CRO InvestorsMorningstar • Mon, Dec 31, 2012
-
-
-
-
-
Hedge Funds Are Buying Up These 20 Healthcare StocksKapitall • Thu, Jan 26, 2012
-
5 Stocks To Survive EurogeddonMyPlanIQ • Mon, Jan 23, 2012
-
-
Leading CROs Will Gain From Drug Research ReboundMorningstar • Mon, Oct 3, 2011
-
9 Of Richard F. Aster's Q2 Stock HoldingsDividend Screen • Tue, Sep 6, 2011 -
-
-
-
-
-
CRO Investment Opportunities Remain CompellingMorningstar • Thu, Nov 11, 2010
-
-
-
-
CROs Look to Put a Tough 2010 in the Rearview MirrorMorningstar • Fri, Apr 9, 2010
-
ICON plc ADR Q2 2009 Earnings Call TranscriptWed, Jul 22, 2009
-
ICON Clinical PLC, Q3 2008 Earnings Call TranscriptWed, Oct 22, 2008
-
ICON plc Q2 2008 Earnings Call TranscriptTue, Jul 22, 2008
-
Business Wire (Apr 25, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 5, 2013)
-
Business Wire (Feb 4, 2013)
-
Business Wire (Dec 21, 2012)
-
Business Wire (Dec 3, 2012)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Nov 6, 2012)
-
at MarketWatch.com (Aug 8, 2012)
-
Business Wire (Jun 12, 2012)
-
Business Wire (Dec 27, 2011)
-
at MarketWatch.com (Mar 1, 2011)
-
at CNBC.com (Feb 8, 2011)
-
at CNBC.com (Nov 16, 2010)
-
at CNBC.com (Nov 8, 2010)
ICLR vs. ETF Alternatives
Company Description
Currently, there's no company description for ICLR.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 25, 6:41 AM ICON (ICLR): Q1 EPS of $0.36 beats by $0.02. Revenue of $317M (+26% Y/Y) beats by $14.71M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, February 19, 6:21 AM ICON Brand Group (ICLR): Q4 EPS of $0.34 beats by $0.01. Revenue of $300M (+24% Y/Y) beats by $9M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, November 1, 2012, 6:23 AM Icon (ICLR): Q3 EPS of $0.29 beats by $0.02. Revenue of $286M (+18.6% Y/Y) beats by $4M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, July 24, 2012, 6:24 AM ICON (ICLR): Q2 EPS of $0.21 misses by $0.01. Revenue of $277M (+18.9% Y/Y) beats by $11M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, April 24, 2012, 8:33 AM ICON (ICLR): Q1 EPS of $0.15 in-line. Revenue of $252M (+10% Y/Y) misses by $4M. (PR) Comment! [Earnings, Healthcare]
- Thursday, February 16, 2012, 7:48 AM ICON (ICLR): Q4 EPS of $0.07 misses by $0.01. Revenue of $243M (+4.7% Y/Y) misses by $8M. (PR) Comment! [Earnings, Healthcare]
- Monday, October 10, 2011, 10:30 AM ICON plc (ICLR -0.2%) lags the general market after JPMorgan cut the shares to neutral over concerns that near-term expenses from the company's partnerships will cut into margins. Comment! [Healthcare, On the Move]
-
- View all 1 replies
-
-
- View all 2 replies
-
-
Energysystems: I'd take $JAH over $CAB, one is a manufacturer of the products the other sells. Plus, really diversified.
-
Cockrell Group
Baird analyst raised price tgt on Covance $CVD to $54 from $52; and Icon $ICLR price target to $22 from $21. - View all 0 replies
-
Cockrell Group
Baird analyst raised price tgt on Covance $CVD to $54 from $52; and Icon $ICLR price target to $22 from $21. - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
Biggest Players Within Medical Laboratories And Research Industry ++ http://t.co/qNeUzk4 ++ $LH $DGX $CVD $ALR $PPDI $ICLR $IRWD $PRXL - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 1 replies
-
-
- View all 2 replies
-
-
Energysystems: I'd take $JAH over $CAB, one is a manufacturer of the products the other sells. Plus, really diversified.